Johnson & Johnson announced Tuesday that it would pay $8.9 billion to resolve all allegations that talc in its baby powder and other products caused cancer. That amount was more than quadruple ...

Johnson & Johnson will stop selling talc-based baby powder globally in 2023, the drugmaker said on Thursday, more than two years after it ended US sales of a product that drew thousands of ...

Aug 11 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab will stop selling talc-based baby powder globally in 2023, the drugmaker said on Thursday, more than two years after it ended U.S. sales ...

Johnson & Johnson announced Tuesday that the company has agreed to pay $8.9 billion over 25 years to settle "all current and future" claims that the company's baby powder and other cosmetic talc ...

Thousands of lawsuits have alleged the company's talcum products caused cancer Johnson & Johnson has agreed to pay $8.9 billion to settle lawsuits that alleged its talcum-based baby powder caused ...

Johnson & Johnson on Tuesday said that it's ready to pay $8.9 billion over lawsuits regarding its talc-based baby powder, a move the company hopes will resolve claims and suits over the product's ...

Johnson & Johnson has denied its products were unsafe, and did not admit fault in the settlement. Recent studies have supported a possible link between the baby powder and cancer.

Pharmaceutical company Johnson & Johnson announced Thursday that it will stop selling talc-based baby powder in 2023. The company said that the switch from talc-based to cornstarch-based baby ...

A $10 billion settlement to end litigation over Johnson & Johnson's baby powder, which was recalled after it was alleged to cause cancer in women, will be put to a judge on Tuesday ...

(Johnson & Johnson via AP) The original script — based on co-founder James Wood Johnson’s signature — will still be seen for now on consumer products like baby shampoo from Kenvue, a new ...